Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 in Refractory Colorectal Cancer
NCT00337545Phase 2Completed
- Sponsor
- Swedish Health Services
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in colorectal cancer (CRC), sponsored by Swedish Health Services. Started May 2006; status: completed.
02
Drugs
everolimus
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00337545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337545.